期刊文献+

国外规范医生处方行为的措施及其对我国的启示 被引量:6

在线阅读 下载PDF
导出
摘要 目的为规范我国医生处方行为提供参考。方法介绍和分析国外规范医生处方行为的主要措施。结果与结论可以通过借鉴国外经验,结合我国国情制订相应措施,促使医生处方行为得到有效的规范。
出处 《中国药业》 CAS 2010年第24期9-10,共2页 China Pharmaceuticals
作者简介 刘玉聪,硕士研究生,研究方向为医药投资效益与管理、药物经济学,(电子信箱)yucong_liu@yahoo.cn; 孙利华,教授,博士研究生导师,本文通讯作者,(电话)024-23986553(电子信箱)slh-3632@163.com。
  • 相关文献

参考文献11

  • 1Silvia M.Ess,Sebastian Sehneeweiss,Thomas D.Szucs.European healthcare policies for controlling drug expenditure[J].Pharmaeoeeonomies,2003,21(2):89-103.
  • 2Sehulenburg JM,Uber A.Current issues in German healthcare[J].Pharmacoeconoroics,1997,12(5):517-523.
  • 3Hans V,Hogerzeil.Promoting rational prescribing:an international perspective[J].BrJ elin Pharmac,1995,(39):3.
  • 4Pharmacy Benefit Management Savings or Shackles? Healtheare Business Digest Online[EB/OL1.http://www,mmhc.eom/hcbk/articles/hebd9803/pharmacy.Html.2002.
  • 5R.Fijn,L T.W.de Jang-van den Berg,J.R.B.J.Brouwers,Rational pharmacotherapy in The Netherlands:formulary management in Dutch hospitals[J].Pharm World Sci,1999,21(2).75-76.
  • 6Azeem Majeed,Norman Evans,Panla Head.What can PACT tell us about prescribing in general practice?[J].BMJ,1997(315):1 515-1 519.
  • 7Jacobzone S.Pharmaceutical policies in OECD countries:Reconciling social and industrial goals[R].OECD Labour Market and Social Policy Occasional Papers,2000(40):45.
  • 8Heidrun B.Sturm.Influencing physician prescribing in an international context:the role of systems,policies and patients[D].Groningen:Rijksuniversiteit Groningen,2007:136.
  • 9孙静.英国与德国药品处方预算制度比较[J].中国药事,2003,17(4):255-258. 被引量:2
  • 10董文勇.德国社会医疗保险用药费用控制制度及其对中国的启示[J].环球法律评论,2006,28(2):208-217. 被引量:24

二级参考文献32

  • 1[1]Glennerster,H., Matsaganis,M. and Owens,P. Implementing GP Fundholding: Wild Card or Winning Hand? Buckingham: Open University Press, 1994:89,92
  • 2[2]Mossialos,E. and Mrazek,M. "Entrepreneurial Behaviour in Pharmaceutical Markets and the Effects of Regulation", in Saltman,R., Busse, R. and Mossialos,E. (Eds.), Regulating Entrepreneurial Behaviour in European Health Care Systems. Philadelphia, Pa.: Open University Press, 2002:159
  • 3[3]Delnoij,D. and Brenner,G.. "Importing budget system from other countries: what can we learn from the German drug budget and the British GP fundholding?" Health Policy, 2000, 52:157
  • 4[4]Bloor,K., Maynard,A. and Freemantle,N. "Lessons from international Lessons from international experience in controlling pharmaceutical expenditure II: influencing doctors", British Medical Journal, 1996, 312(7045):1525
  • 5[5]Coulter,A. "Evaluating general practice fundholding in the United Kingdom". European Journal of Public Health, 1995, 5:233
  • 6[6]Audit Commission. A prescription for improvement: Towards More Rational Prescribing in General Practice, London: HMSO, 1994, 42(8926):9
  • 7[7]Brenner,G. "Drug policy and control of drug expenditure in Germany", Paper prepared for the Concerted Action Network for setting an evaluation team of control of drug expenditure in Europe (contracted number CHRX-CT-94 0700), Cologne, 1995
  • 8[8]Wilson,R.P.H., Hatcher,J., Barton,S. and Walley,T. "General practice fundholders'prescribing savings in one region of the United Kindom 1991-1994". Health Policy, 1997, 42:29
  • 9[9]Gosden,T., Torgerson,D.J. "The effect of fundholding on prescribing and referral costs: a review of the evidence". Health Policy, 1997, 40:103
  • 10[10]Le Grand,J., Mays,N. and Mulligan,J.A. Learning form the NHS Internal Market, A review of the Evidence. London: King's Fund, 1998

共引文献27

同被引文献66

引证文献6

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部